MEDIA STATEMENT
KINGSTON, ONTARIO – “Thanks to the collaborative efforts of health-care partners throughout the southeast region, as of Jan. 18, we have administered over 1,900 doses of the Pfizer-BioNTech vaccine to a portion of individuals in the first priority group in long-term care and high-risk retirement homes. This uses the entire shipment received Jan. 12.
“Within a week of receiving the first shipment of vaccine, a second shipment was received at Kingston Health Sciences Centre (KHSC). Following a successful pilot to bring vaccine directly to those in vulnerable care homes, the second shipment of about 1,900 doses will be distributed equally among the three public health agencies in the region, and administered by mobile vaccination teams.
“We are aware that due to work to expand its European manufacturing facility, production of the Pfizer-BioNtech COVD-19 vaccine will be reduced for a few weeks and will impact deliveries to Canada. We are working with our partners to adjust our plans accordingly.
“We are confident that everyone who chooses to be vaccinated for COVID-19 will be able to receive the vaccine when there is sufficient supply of this and other vaccines in the coming months, and as vaccination and distribution are expanded beyond hospital sites.
“We need to be patient. With limited vaccine supply, we must focus initially on vaccinating the most vulnerable, those in long-term care homes and high-risk retirement homes, where the risk of infection, serious illness and spreading the virus are much higher.”
- Dr. David Pichora, president and CEO, Kingston Health Sciences Centre
MEDIA INQUIRIES TO:
Kristen Lipscombe
Cell: 613-583-1377
Office: 613-549-6666, ext. 6875
Email: @email
